Fighting COVID-19 and other infections with a cancer drug
New findings support the potential use of repurposed cancer drug to suppress inflammation in COVID-19 and other infectious diseases. …
New findings support the potential use of repurposed cancer drug to suppress inflammation in COVID-19 and other infectious diseases. …
A retrospective study with a large cohort links an autoimmune condition to SARS-CoV-2 infection and vaccination. …
A new study has shown that in mice it is possible to correct circadian disruptions seen in Alzheimer’s disease with time-restricted feeding, a type of intermittent fasting focused on limiting the daily eating window without limiting the amount of food consumed. …
Study finds ambient air pollution is associated with specific aspects of dementia, such as worse verbal fluency. …
The combination of immunotherapy and chemotherapy showed a significant reduction in disease growth in patients with advanced endometrial cancer. …
Researchers studied ultraviolet (UV) light-emitting devices used to cure gel manicures and found that their use leads to cell death and cancer-causing mutations in human cells. …
Researchers used human brain organoids to document how alcohol exposure impairs the development and functioning of new brain cells. …
A polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer. …
An international team of scientists has created the first pan-cancer mycobiome atlas — a survey of 35 types of cancer and their associated fungi. …
New findings suggest that hereditary hemochromatosis, a condition that results in the body absorbing too much iron, is a risk factor for movement disorders like Parkinson’s disease. …
End of content
End of content